BTIG Initiates Coverage On Mobia Medical with Buy Rating, Announces Price Target of $19

Benzinga Newsdesk www.benzinga.com Neutral 55.9%

Neg 0% Neu 55.9% Pos 0%

BTIG analyst Ryan Zimmerman initiates coverage on Mobia Medical (NASDAQ:MOBI) with a Buy rating and announces Price Target of $19.